JPRN-UMIN000002791已完成2 期
Phase II trial of adjuvant chemotherapy with modified medication of S-1 for pancreatic cancer - Phase II trial of adjuvant chemotherapy with S-1 for pancreatic cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Watery diarrhea 2)Severe mental disorder 3)Active infection 4)Severe complications, such as ileus, heart failure and renal failure 5)Symptomatic pulmonary fibrosis or interstitial pneumonia 6)History of severe anaphylaxies 7)Marked pleural or peritoneal effusion 8)Active concomitant malignancy 9)Treatment with phenytoin, potassium warfarin or flucytosine
研究者
相似试验
招募中
1 期
Phase I trial of adjuvant chemotherapy with modified S-1 and propagermanium for pancreatic cancerpancreatic cancerJPRN-UMIN000017715Osaka University Hospital10
未知
2 期
A Phase II trial of neoadjuvant chemotherapy with S-1 and fractional cisplatin for locally advanced gastric cancerGastric cancerJPRN-UMIN000001777Division of Biological Regulation and Oncology, Department of Surgery, Graduate School of Medicine, Tohoku University25
招募中
不适用
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)radically resectable advanced gastric carcinomaJPRN-UMIN000003642Kitasato University School of Medicine40
招募中
2 期
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50
已完成
1 期
Phase I/II trial of neoadjuvant chemotherapy with cisplatin and weekly paclitaxel in patients with stage Ib2- IIb uterine cervical cancerpatients with clinical stage Ib2, IIa(primary tumor diameter4 or more cm),IIb uterine cervical cancerJPRN-UMIN000002636Hyogo Cancer Center40
